Chitosan-based rechargeable long-term antimicrobial and biofilm-controlling systems.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 18470925.
- Also identified by DOI 10.1002/jbm.a.32040.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Chitosan, a natural cationic polymer, strongly binds anionic antibiotics (e.g., rifampin) through the formation of ionic complexes. The new system shows sustained rifampin release, leading to potent antimicrobial and biofilm-controlling functions against gram-positive bacteria including Staphylococcus epidermidis and Staphylococcus aureus, which are responsible for a wide range of medical device-related infections, for longer than 30 days. Moreover, the released drugs can be recharged to further extend antimicrobial durations. Drug release mechanisms and potential applications of the new system are also discussed.
Medical subject headings
- Anti-Infective Agents
- Biofilms
- Chitosan